Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NGM
Company Announcements
NGM Biopharmaceuticals Advances in Cancer Cachexia Treatment with NGM120 Study
24d ago
NGM
Premium
Company Announcements
NGM Biopharmaceuticals’ Strategic Merger and Corporate Transformation
1y ago
8K
NGM
Premium
Company Announcements
Ngm Biopharmaceuticals Merger at Risk: Legal Hurdles Could Jeopardize Deal and Financial Stability
1y ago
NGM
Premium
The Fly
Oracle, Dollar General upgraded: Wall Street’s top analyst calls
1y ago
AM
DG
Premium
The Fly
NGM downgraded to Market Perform from Outperform at Raymond James
1y ago
NGM
Premium
The Fly
NGM Biopharmaceuticals reports Q4 EPS (33c), consensus (39c)
1y ago
NGM
Premium
The Fly
NGM Biopharmaceuticals downgraded to Market Perform from Outperform at TD Cowen
1y ago
NGM
Premium
The Fly
NGM Biopharmaceuticals downgraded to Neutral from Buy at Citi
1y ago
NGM
Premium
Company Announcements
NGM Biopharmaceuticals Acquisition by Atlas Neon Parent
1y ago
8K
NGM
Premium
The Fly
NGM Biopharmaceuticals trading resumes
1y ago
NGM
Premium
The Fly
NGM to be acquired by affiliates of The Column Group for $1.55 per share
1y ago
NGM
Premium
The Fly
NGM Biopharmaceuticals trading halted, news pending
1y ago
NGM
Premium
Pre-Earnings
NGM Earnings this Week: How Will it Perform?
1y ago
NGM
Premium
Market News
NGM Biopharmaceuticals Regains Nasdaq Compliance Status
1y ago
8K
NGM
Premium
The Fly
NGM announces new data from NGM707 trial, outlines strategies for candidates
2y ago
NGM
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2y ago
NGM
NVS
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2y ago
NGM
NVS
Premium
The Fly
NGM Biopharma confirms The Column Group interested in acquiring company
2y ago
NGM
Premium
The Fly
NGM Biopharmaceuticals’ aldafermin granted orphan status
2y ago
NGM
Premium
The Fly
NGM Biopharmaceuticals price target lowered to $3.50 from $7.00 at B. Riley
2y ago
NGM
Premium
The Fly
NGM Biopharmaceuticals reports Phase 2b study results from ALPINE 4 trial
2y ago
NGM
Premium
The Fly
NGM Biopharmaceuticals price target lowered to $4 from $9 at TD Cowen
2y ago
NGM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
